Fipexide
Fipexide, a piperazine-class psychoactive drug developed in 1983, was formerly used as a nootropic for senile dementia. Its clinical use was discontinued due to rare adverse effects like hepatitis. Current research applications may include studies of its neuropharmacology and mechanisms underlying its discontinued therapeutic effects.
Product Specifications
CAS Number
34161-24-5
Product Name Alternative
Neurotransmission, parachloro-phenossiacetic, nootropic, inhibit, Fipexide, Inhibitor, cognitive, DAT, dementia, dopaminergic, DopamineReceptor, Dopamine, Dopamine Transporter, Dopamine Receptor, Adenylate Cyclase, Adenylyl cyclase, acid, SLC6A3, senile, performance
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
97.60% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.14 mM) ; DMSO:55 mg/mL (141.45 mM)
Smiles
Clc1ccc (OCC (=O) N2CCN (Cc3ccc4OCOc4c3) CC2) cc1
Molecular Formula
C20H21ClN2O4
Molecular Weight
388.84
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
127702-HRP 100 µL
HABP2 (Hyaluronan-binding Protein 2, Factor VII-activating Protease, Factor Seven-activating Protease, FSAP, HGFAL, PHBP, Hepatocyte Growth Factor Activator-like Protein, Plasma Hyaluronan-binding Protein) (HRP)
Sign In for Pricing
View Details